×
About 10,748 results

ALLMedicine™ Idiopathic Pulmonary Fibrosis Center

Research & Reviews  3,552 results

Newer 3D lung models starting to remake research
https://www.mdedge.com/chestphysician/article/258270/pulmonology/newer-3d-lung-models-starting-remake-research
Christine Kilgore, MDedge News

Sep 28th, 2022 - Pulmonologist-scientist Veena B. Antony, MD, professor of medicine at the University of Alabama in Birmingham, grows “pulmospheres” in her lab.

Increasing primary care doctors’ knowledge of IPF could speed up diagnoses, suggests white paper
https://www.mdedge.com/internalmedicine/article/258268/pulmonology/increasing-primary-care-doctors-knowledge-ipf-could
Heidi Splete

Sep 28th, 2022 - Prompt diagnosis of idiopathic pulmonary fibrosis is essential to reduce mortality, and improving education of primary care providers can help, suggests a new white paper. The nonspecific nature of the symptoms of idiopathic pulmonary fibrosis (IP.

USP13 Deficiency Impairs Autophagy and Facilitates Age-related Lung Fibrosis.
https://doi.org/10.1165/rcmb.2022-0002OC
American Journal of Respiratory Cell and Molecular Biology; Liu Y, Li Z et. al.

Sep 24th, 2022 - Idiopathic pulmonary fibrosis (IPF) is an age-related disease. Failure of the proteostasis network with age, including insufficient autophagy, contributes to the pathology of IPF. Mechanisms underlying autophagy disruption in IPF are unclear and m...

Novel tracers for molecular imaging of interstitial lung disease: A state of the art re...
https://doi.org/10.1016/j.autrev.2022.103202
Autoimmunity Reviews; Broens B, Duitman JW et. al.

Sep 24th, 2022 - Interstitial lung disease is an overarching term for a wide range of disorders characterized by inflammation and/or fibrosis in the lungs. Most prevalent forms, among others, include idiopathic pulmonary fibrosis (IPF) and connective tissue diseas...

Air pollutants, genetic susceptibility and risk of incident idiopathic pulmonary fibrosis.
https://doi.org/10.1183/13993003.00777-2022
The European Respiratory Journal; Cui F, Sun Y et. al.

Sep 23rd, 2022 - Air pollutants are considered as non-negligible risk factors of idiopathic pulmonary fibrosis (IPF). However, the relationship between long-term air pollution and the incidence of IPF is unknown. To explore the associations of air pollutants with ...

see more →

Guidelines  6 results

Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults:...
https://doi.org/10.1164/rccm.202202-0399ST
American Journal of Respiratory and Critical Care Medicine; Raghu G, Remy-Jardin M et. al.

Apr 30th, 2022 - Background: This American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and Asociación Latinoamericana de Tórax guideline updates prior idiopathic pulmonary fibrosis (IPF) guidelines and addresses the progression of...

S2K Guideline for Diagnosis of Idiopathic Pulmonary Fibrosis.
https://doi.org/10.1159/000512315
Respiration; International Review of Thoracic Diseases; Behr J, Günther A et. al.

Jan 25th, 2021 - Idiopathic pulmonary fibrosis (IPF) is a severe and often fatal disease. Diagnosis of IPF requires considerable expertise and experience. Since the publication of the international IPF guideline in the year 2011 and the update 2018 several studies...

Guidelines of the Polish Respiratory Society for diagnosis and treatment of idiopathic ...
https://doi.org/10.5603/ARM.2020.0081
Advances in Respiratory Medicine; Piotrowski WJ, Bestry I et. al.

Mar 11th, 2020 - This document presents the guidelines of the Polish Respiratory Society (PTChP, Polskie Towarzystwo Chorób Płuc) for diagnosis and treatment of idiopathic pulmonary fibrosis (IPF), developed by agroup of Polish experts. The recommendations were de...

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Pract...
https://doi.org/10.1164/rccm.201807-1255ST
American Journal of Respiratory and Critical Care Medicine; Raghu G, Remy-Jardin M et. al.

Sep 1st, 2018 - This document provides clinical recommendations for the diagnosis of idiopathic pulmonary fibrosis (IPF). It represents a collaborative effort between the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and L...

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmo...
https://doi.org/10.1164/rccm.201506-1063ST
American Journal of Respiratory and Critical Care Medicine; Raghu G, Rochwerg B et. al.

Jul 16th, 2015 - This document updates the American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin American Thoracic Association guideline on idiopathic pulmonary fibrosis treatment. Systematic reviews and, when appropriate, meta-...

see more →

Drugs  32 results see all →

Clinicaltrials.gov  408 results

Database and Biobank of Patients With Hypersensitivity Pneumonitis
https://clinicaltrials.gov/ct2/show/NCT05549635

Sep 22nd, 2022 - Sub-study of the main Pulmonary Fibrosis Biomarker (PFBIO) cohort (NCT02755441), recruiting patients with an MDT-diagnosis of hypersensitivity pneumonitis (HP). Patients are included for the collection of blood samples and regular clinical data. T...

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
https://clinicaltrials.gov/ct2/show/NCT04708782

Sep 22nd, 2022 - Study RIN-PF-301 is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of inhaled treprostinil in subjects with IPF over a 52-week period. Subjects will be randomly allocated 1:1 to receive inhale...

Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
https://clinicaltrials.gov/ct2/show/NCT04905693

Sep 22nd, 2022 - Study RIN-PF-302 is a Phase 3, multicenter, open-label extension (OLE) study for eligible subjects who completed Study RIN-PF-301 or Study RIN-PF-303 to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopa...

CSL312 Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis
https://clinicaltrials.gov/ct2/show/NCT05130970

Sep 22nd, 2022 - This is a prospective, phase 2a, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of CSL312 in subjects with idiopathic pulmonary fibrosis (IPF).

Evaluation of Oral ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
https://clinicaltrials.gov/ct2/show/NCT04643769

Sep 22nd, 2022 - This Phase 1b trial is a double-blind, placebo-controlled, multiple ascending dose study to evaluate the safety and tolerability of oral ORIN1001 at 25 mg, 50 mg or 100 mg administered daily for up to 28 days in adult subjects with idiopathic pulm...

see more →

News  296 results

Newer 3D lung models starting to remake research
https://www.mdedge.com/chestphysician/article/258270/pulmonology/newer-3d-lung-models-starting-remake-research
Christine Kilgore, MDedge News

Sep 28th, 2022 - Pulmonologist-scientist Veena B. Antony, MD, professor of medicine at the University of Alabama in Birmingham, grows “pulmospheres” in her lab.

Increasing primary care doctors’ knowledge of IPF could speed up diagnoses, suggests white paper
https://www.mdedge.com/internalmedicine/article/258268/pulmonology/increasing-primary-care-doctors-knowledge-ipf-could
Heidi Splete

Sep 28th, 2022 - Prompt diagnosis of idiopathic pulmonary fibrosis is essential to reduce mortality, and improving education of primary care providers can help, suggests a new white paper. The nonspecific nature of the symptoms of idiopathic pulmonary fibrosis (IP.

Increasing Primary Care Doctors' Knowledge of IPF Could Speed Up Diagnoses, Suggests White Paper
https://www.medscape.com/viewarticle/981612

Sep 28th, 2022 - Prompt diagnosis of idiopathic pulmonary fibrosis is essential to reduce mortality, and improving education of primary care providers can help, suggests a new white paper. The nonspecific nature of the symptoms of idiopathic pulmonary fibrosis (IP...

ILD on the Rise, Doctors Offer Tips for Diagnosing Deadly Disease
https://www.medscape.com/viewarticle/980795

Sep 14th, 2022 - Too often, when patients come to see Tejaswini Kulkarni, MD, with shortness of breath and cough and are diagnosed with interstitial lung disease (ILD), they are past the point when treatments would most benefit them. "There is definitely a delay f...

ILD on the rise: Doctors offer tips for diagnosing deadly disease
https://www.mdedge.com/internalmedicine/article/257756/pulmonology/ild-rise-doctors-offer-tips-diagnosing-deadly-disease
Thomas R. Collins

Sep 12th, 2022 - Too often, when patients come to see Tejaswini Kulkarni, MD, with shortness of breath and cough and are diagnosed with interstitial lung disease (ILD), they are past the point when treatments would most benefit them. “There is definitely a delay f.

see more →

Patient Education  5 results see all →